RXRX - Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
IEX Last Trade
7.27
-0.140 -1.926%
Share volume: 3,550,212
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.41
-0.14
-1.89%
Summary score
8%
Profitability
0%
Dept financing
8%
Liquidity
71%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.64%
Return on assets
-10.98%
Return on sales
-1068.79%
Return on invested capital
-156.43%
Total debt ratio
25.6%
Debt ratio change over timeo
-1.23%
Current Ratio
7.91%
Quick Ratio
7.91%
Cash Position Ratio
6.72%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.11%
Return on assets
-15.11%
Return on sales
-823.41%
Return on invested capital
-69.46%
Total debt ratio
29.36%
Debt ratio change over timeo
-1.36%
Current Ratio
4.37%
Quick Ratio
4.37%
Cash Position Ratio
3.97%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-22.78%
Return on assets
-17.27%
Return on sales
-698.42%
Return on invested capital
-65.12%
Total debt ratio
28.09%
Debt ratio change over time
-1.37%
Current Ratio
4.65%
Quick Ratio
4.65%
Cash Position Ratio
4.01%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.3%
Return on assets
-89.79%
Return on sales
670.12%
Return on invested capital
9.85%
Total debt ratio
-123.09%
Debt ratio change over time
-1.23%
Current Ratio
-6.25%
Quick Ratio
-6.25%
Cash Position Ratio
-5.54%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RXRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.64% | 13.79% | 34.47% | 7.43% |
| Return on assets | -10.98% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1068.79% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -156.43% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 25.6% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.23% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 4.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.37% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.97% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 14% | 34% |
| Short-term ratios | RXRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.11% | 13.77% | 13.25% | 3.8% |
| Return on assets | -15.11% | 2.43% | 1.89% | 3.09% |
| Return on sales | -823.41% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -69.46% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 29.36% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.36% | 46.38% | -72.08% | 1.51% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 4.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.37% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.97% | 0.36% | 1.28% | 2.93% |
| Liquididy | 69% | 11% | 28% | 68% |